ArticleAnnals of neurosciences2014
Central depressant and nootropic effects of daytime melatonin in mice.
Article in Annals of neurosciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 19 citations in OpenAlex.
- Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders.Current neuropharmacology · 2020Review
- Circadian dysrhythmia-linked diabetes mellitus: Examining melatonin's roles in prophylaxis and management.World journal of diabetes · 2018Review
- Effects of long‑term scopolamine treatment on cognitive deficits and calcium binding proteins immunoreactivities in the mouse hippocampus.Molecular medicine reports · 2018Article
- Exogenous daytime melatonin modulates response of adolescent mice in a repeated unpredictable stress paradigm.Naunyn-Schmiedeberg's archives of pharmacology · 2017Article
- Exogenous Testosterone, Aging, and Changes in Behavioral Response of Gonadally Intact Male Mice.Journal of experimental neuroscience · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEffects of orally administered daytime melatonin on novelty induced behaviors and spatial working memory in mice were evaluated using the open field, the Y maze and the radial arm maze. PURPOSE: To ascertain the possible nootropic and/or central excitatory or inhibitory effects of daytime oral melatonin in mice.
methodsAdult male mice from our colony, assigned to three and four groups for open field tests and memory tests respectively were given vehicle (normal saline), a standard drug Scopolamine at 0.5 mg/kg i.p, single dose, 30 minutes before behavioral study) or one of two doses of melatonin (5 and 10 mg/kg daily for a period of 30 days). All administrations were done between 8.00 a.m. and 9.00 a.m. daily. Behavioral tests were carried out on day 30 after administration. Results were analysed using a one-way ANOVA followed by a posthoc test (Student-Newman-Keul's) and expressed as mean ± S.E.M.
resultsOpen field tests revealed a significant reduction in rearing and grooming behaviors at both doses tested while no significant changes in horizontal locomotion were seen. Y maze studies showed an improvement in spatial memory in mice that received 5 mg/kg of melatonin when compared to scopolamine control. At 10 mg/kg, no significant improvement was seen. A significant increase in the radial arm maze spatial working memory following melatonin administration was seen at 5 mg/kg and 10 mg/kg compared to scopolamine control. Radial arm maze exploration was also significantly reduced.
conclusionThe study demonstrates the ability of exogenously administered melatonin, to affect both central excitation and spatial working memory in mice even when given orally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.